Healthcare provider profile · identity verified

Marisa Gefen, M.D.

Internal Medicine · PHILADELPHIA, PA · NPI 1386846806

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	659	135
Amlodipine Besylate	Amlodipine Besylate	484	99
Omeprazole	Omeprazole	246	49
Losartan Potassium	Losartan Potassium	228	41
Duloxetine Hcl	Duloxetine Hcl	226	43
Albuterol Sulfate Hfa	Albuterol Sulfate	225	43
Carvedilol	Carvedilol	161	28
Metoprolol Succinate	Metoprolol Succinate	145	34
Metformin Hcl	Metformin Hcl	144	33
Gabapentin	Gabapentin	133	27
Lisinopril	Lisinopril	132	33
Rosuvastatin Calcium	Rosuvastatin Calcium	132	29
Furosemide	Furosemide	122	25
Jardiance	Empagliflozin	118	19
Spironolactone	Spironolactone	110	23
Ozempic	Semaglutide	107	21
Hydrochlorothiazide	Hydrochlorothiazide	99	30
Eliquis	Apixaban	87	17
Escitalopram Oxalate	Escitalopram Oxalate	83	16
Nifedipine Er	Nifedipine	83	12
Quetiapine Fumarate	Quetiapine Fumarate	82	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	77	16
Diclofenac Sodium	Diclofenac Sodium	74	16
Simvastatin	Simvastatin	69	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	suppressed
Sertraline Hcl	Sertraline Hcl	56	12
Famotidine	Famotidine	54	11
Fluticasone Propionate	Fluticasone Propionate	54	13
Breo Ellipta	Fluticasone/Vilanterol	53	suppressed
Bupropion Xl	Bupropion Hcl	50	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	49	suppressed
Potassium Chloride	Potassium Chloride	49	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Montelukast Sodium	Montelukast Sodium	45	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	44	suppressed
Alendronate Sodium	Alendronate Sodium	41	11
Entresto	Sacubitril/Valsartan	40	suppressed
Mounjaro	Tirzepatide	38	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	37	14
Telmisartan	Telmisartan	37	suppressed
Allopurinol	Allopurinol	36	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Trazodone Hcl	Trazodone Hcl	33	suppressed
Myrbetriq	Mirabegron	32	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	31	11
Incruse Ellipta	Umeclidinium Bromide	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	suppressed
Prednisone	Prednisone	29	17
Aripiprazole	Aripiprazole	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Linzess	Linaclotide	28	suppressed
Metformin Hcl Er	Metformin Hcl	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Topiramate	Topiramate	28	suppressed
Baclofen	Baclofen	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Lurasidone Hcl	Lurasidone Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Irbesartan	Irbesartan	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Anastrozole	Anastrozole	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Memantine Hcl Er	Memantine Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Valsartan	Valsartan	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Naltrexone Hcl	Naltrexone Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Lacosamide	Lacosamide	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Diazepam	Diazepam	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Dutasteride	Dutasteride	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Methimazole	Methimazole	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Atenolol	Atenolol	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Glipizide	Glipizide	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Wegovy	Semaglutide	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Lovastatin	Lovastatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error